Effects of catecholamine-depleting drugs and amphetamine on self-stimulation of brain following various 6-hydroxydopamine treatments.
D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D003864:Depression, Chemical; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D004558:Electric Stimulation; D004567:Electrodes, Implanted; D006892:Hydroxydopamines / Q000494:pharmacology*; D007031:Hypothalamus / Q000187:drug effects; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012653:Self Stimulation; D013268:Stimulation, Chemical; D014443:Tyrosine / Q000494:pharmacology
D002395:Catecholamines; D006892:Hydroxydopamines; D014443:Tyrosine; D012110:Reserpine; D010293:Pargyline; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine